Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms

Thomas Z Armel1, Leslie A Leinwand

  • 1Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA.

Insights

Myosin storage myopathy (MSM) arises from mutations in the MYH7 gene

Area of Science:

  • Muscle physiology and molecular biology
  • Genetics of neuromuscular disorders
  • Protein structure-function relationships

Background:

  • Myosin storage myopathy (MSM) is a congenital myopathy defined by myosin inclusions in type I muscle fibers.
  • Mutations in the beta-myosin heavy chain (MYH7) gene are linked to MSM, with most known mutations in the head region.
  • MSM-associated mutations are uniquely located in the alpha-helical coiled-coil tail of MYH7, a region with uncharacterized pathogenic mechanisms.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying four specific MYH7 mutations (L1793P, R1845W, E1886K, H1901L) responsible for MSM.
  • To elucidate how mutations in the myosin rod region contribute to muscle disease pathogenesis.
  • To establish a framework for understanding other disease-causing mutations in this critical region of MYH7.

Main Methods:

  • Biochemical and biophysical analyses of recombinant proteins carrying MSM mutations.
  • Assessment of protein thermodynamic stability and functional properties.
  • Investigation of myosin filament assembly and stability in vitro.

Main Results:

  • Each of the four studied MSM mutations (L1793P, R1845W, E1886K, H1901L) exhibits distinct molecular phenotypes.
  • The L1793P mutation affects individual protein thermodynamics and function.
  • Mutations R1845W, E1886K, and H1901L lead to varying defects in myosin filament assembly and stability.

Conclusions:

  • MSM can result from multiple distinct molecular mechanisms driven by mutations in the MYH7 rod region.
  • These findings provide the first molecular insights into the pathogenesis of mutations in the myosin rod.
  • This study establishes a foundation for future research into MYH7 rod region mutations and related myopathies.

Related Concept Videos

Overview of Myosin Structure and Function01:15

Overview of Myosin Structure and Function

Myosins are a family of molecular motor proteins, first identified in the skeletal muscles, where they are responsible for muscle contraction. Along with their role in muscle contraction, these proteins also play a role in the intracellular transport of molecules and vesicles. There are twenty-four classes of myosins based on their domain sequence and organization. Of the twenty-four, six classes (Myosin I, Myosin II, Myosin V, Myosin VI, Myosin VII, and Myosin X)  have been well characterized.
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...